Literature DB >> 2959756

Factors influencing circulating OKT8 cell phenotypes in patients with multiple sclerosis.

P J Hughes1, P F Kirk, J Dyas, J A Munro, K I Welsh, D A Compston.   

Abstract

Peripheral blood OKT8 cell phenotypes were correlated with measurements of plasma cortisol and serological evidence for exposure to 15 infectious agents, in longitudinal studies involving 13 patients with multiple sclerosis, 13 of their siblings, nine spouses and 13 unrelated controls; 44/48 individuals were HLA typed. Neither circadian rhythms, nor exposure to any one infectious agent accounted for the serial changes in OKT8 cells but there was an association between the presence of HLA-DR2 and periodic reductions in OKT8 cells irrespective of clinical status. Taken with previously reported serial observations in patients and cohabiting relatives, this finding provides indirect evidence for an interplay between environmental and genetic factors in determining OKT8 cell phenotypes in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959756      PMCID: PMC1032348          DOI: 10.1136/jnnp.50.9.1156

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

2.  A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique.

Authors:  D Riad-Fahmy; G F Read; S J Gaskell; J Dyas; R Hindawi
Journal:  Clin Chem       Date:  1979-05       Impact factor: 8.327

3.  Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies.

Authors:  A W Ritchie; I Oswald; H S Micklem; J E Boyd; R A Elton; E Jazwinska; K James
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-04

4.  Heparin therapy for stroke: hemorrhagic complications and risk factors for intracerebral hemorrhage.

Authors:  M Ramirez-Lassepas; M R Quinones
Journal:  Neurology       Date:  1984-01       Impact factor: 9.910

5.  Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8.

Authors:  G P Rice; D Finney; S L Braheny; R L Knobler; J C Sipe; M B Oldstone
Journal:  J Neuroimmunol       Date:  1984-04       Impact factor: 3.478

6.  Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.

Authors:  E L Reinherz; H L Weiner; S L Hauser; J A Cohen; J A Distaso; S F Schlossman
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

7.  Lymphocyte subpopulations in patients with multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

8.  Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period.

Authors:  S L Hauser; E L Reinherz; C J Hoban; S F Schlossman; H L Weiner
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

9.  Viral infection in patients with multiple sclerosis and HLA-DR matched controls.

Authors:  D A Compston; B N Vakarelis; E Paul; W I McDonald; J R Batchelor; C A Mims
Journal:  Brain       Date:  1986-04       Impact factor: 13.501

10.  Suppressor T cells in family members of patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  Brain       Date:  1986-10       Impact factor: 13.501

View more
  1 in total

1.  Human T-cell lymphotrophic viruses in patients with multiple sclerosis.

Authors:  R J Swingler; P J Hughes; J A Munro; D A Compston
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.